Carregant...

Obatoclax and Lapatinib Interact to Induce Toxic Autophagy through NOXA

Prior studies demonstrated that resistance to the ERBB1/2 inhibitor lapatinib could be overcome by the B cell CLL/lymphoma-2 (BCL-2) family antagonist obatoclax (GX15-070). Coadministration of lapatinib with obatoclax caused synergistic cell killing by eliciting autophagic cell death that was depend...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Tang, Yong, Hamed, Hossein A., Cruickshanks, Nichola, Fisher, Paul B., Grant, Steven, Dent, Paul
Format: Artigo
Idioma:Inglês
Publicat: The American Society for Pharmacology and Experimental Therapeutics 2012
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3310419/
https://ncbi.nlm.nih.gov/pubmed/22219388
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/mol.111.076851
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!